-
1دورية أكاديمية
المؤلفون: Sharma, Abhinav, Green, Jennifer B., Dunning, Allison, Lokhnygina, Yuliya, Al-Khatib, Sana M., Lopes, Renato D., Buse, John B., Lachin, John M., Van de Werf, Frans, Armstrong, Paul W., Kaufman, Keith D., Standl, Eberhard, Chan, Juliana C. N., Distiller, Larry A., Scott, Russell, Peterson, Eric D., Holman, Rury R., TECOS Study Group
المصدر: Diabetes Care; Dec2017, Vol. 40 Issue 12, p1763-1770, 8p, 3 Charts, 1 Graph
مصطلحات موضوعية: TYPE 2 diabetes, ATHEROSCLEROTIC plaque, CARDIOVASCULAR diseases, SITAGLIPTIN, HYPOGLYCEMIC agents, PROPORTIONAL hazards models, TREATMENT of diabetes, ATHEROSCLEROSIS prevention, TYPE 2 diabetes complications, ATHEROSCLEROSIS, CLINICAL trials, CAUSES of death, TREATMENT effectiveness, BLIND experiment
-
2دورية أكاديمية
المؤلفون: Bethel, M. Angelyn, Engel, Samuel S., Green, Jennifer B., Zhen Huang, Josse, Robert G., Kaufman, Keith D., Standl, Eberhard, Suryawanshi, Shailaja, Van de Werf, Frans, McGuire, Darren K., Peterson, Eric D., Holman, Rury R., Huang, Zhen, TECOS Study Group
المصدر: Diabetes Care; Apr2017, Vol. 40 Issue 4, p494-501, 8p, 4 Charts, 1 Graph
مصطلحات موضوعية: SITAGLIPTIN, DRUG efficacy, TYPE 2 diabetes treatment, DIABETES in old age, HYPOGLYCEMIC agents, THERAPEUTICS, COMPARATIVE studies, GLYCOSYLATED hemoglobin, HYPOGLYCEMIA, LONGITUDINAL method, RESEARCH methodology, MEDICAL cooperation, MYOCARDIAL infarction, TYPE 2 diabetes, RESEARCH, STATISTICAL sampling, STROKE, EVALUATION research, BODY mass index, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment
-
3دورية أكاديمية
المؤلفون: Cornel, Jan H, Bakris, George L, Stevens, Susanna R, Alvarsson, Michael, Bax, Willem A, Chuang, Lee-Ming, Engel, Samuel S, Lopes, Renato D, McGuire, Darren K, Riefflin, Axel, Rodbard, Helena Wachslicht, Sinay, Isaac, Tankova, Tsvetalina, Wainstein, Julio, Peterson, Eric D, Holman, Rury R, TECOS Study Group
المصدر: Diabetes Care; Dec2016, Vol. 39 Issue 12, p2304-2310, 7p
مصطلحات موضوعية: CARDIOVASCULAR disease prevention, THERAPEUTIC use of protease inhibitors, CHRONIC kidney failure complications, TYPE 2 diabetes complications, CARDIOVASCULAR diseases, CHRONIC kidney failure, COMPARATIVE studies, GLOMERULAR filtration rate, HYPOGLYCEMIC agents, KIDNEYS, RESEARCH methodology, MEDICAL cooperation, TYPE 2 diabetes, RESEARCH, PROTEASE inhibitors, EVALUATION research, TREATMENT effectiveness, BLIND experiment, DISEASE complications, PHARMACODYNAMICS, PREVENTION
-
4دورية أكاديمية
المؤلفون: Pagidipati, Neha J.1 neha.pagidipati@dm.duke.edu, Navar, Ann Marie1, Pieper, Karen S.1, Green, Jennifer B.1, Bethel, M. Angelyn2, Armstrong, Paul W.3, Josse, Robert G.4, McGuire, Darren K.5, Lokhnygina, Yuliya1, Cornel, Jan H.6, Halvorsen, Sigrun7, Strandberg, Timo E.8,9, Delibasi, Tuncay10, Holman, Rury R.2, Peterson, Eric D.1, TECOS Study Group (CORPORATE AUTHOR)
المصدر: Circulation. 9/26/2017, Vol. 136 Issue 13, p1193-1203. 11p.
مصطلحات موضوعية: *CARDIOVASCULAR disease prevention, *PEOPLE with diabetes, *DIABETES, *ASPIRIN, *ACE inhibitors, *HYPOGLYCEMIC agents, *TYPE 2 diabetes complications, *ANGIOTENSIN receptors, *BLOOD pressure, *CARDIOVASCULAR diseases, *COMPARATIVE studies, *LONGITUDINAL method, *LOW density lipoproteins, *RESEARCH methodology, *MEDICAL cooperation, *TYPE 2 diabetes, *RESEARCH, *RESEARCH funding, *SMOKING, *LOGISTIC regression analysis, *EVALUATION research, *TREATMENT effectiveness, *PROPORTIONAL hazards models, *BLIND experiment, *DISEASE complications, *THERAPEUTICS, CARDIOVASCULAR disease related mortality, DISEASE relapse prevention
-
5دورية أكاديمية
المؤلفون: Agbaje, Olorunsola F.1 (AUTHOR) olorunsola.agbaje@dtu.ox.ac.uk, Coleman, Ruth L.1 (AUTHOR), Hattersley, Andrew T.2 (AUTHOR), Jones, Angus G.2 (AUTHOR), Pearson, Ewan R.3 (AUTHOR), Shields, Beverley M.2 (AUTHOR), Holman, Rury R.1 (AUTHOR), MASTERMIND consortium (CORPORATE AUTHOR)
المصدر: Diabetes Research & Clinical Practice. Aug2020, Vol. 166, pN.PAG-N.PAG. 1p. 3 Charts.
مصطلحات موضوعية: *TYPE 2 diabetes, *INDIVIDUALIZED medicine, *DURABILITY, *RESEARCH, *HYPOGLYCEMIC sulfonylureas, *COMBINATION drug therapy, *TIME, *RESEARCH methodology, *ARTHRITIS Impact Measurement Scales, *SULFONYLUREAS, *HYPOGLYCEMIC agents, *BLOOD sugar, *PROGNOSIS, *EVALUATION research, *MEDICAL cooperation, *INSULIN, *TREATMENT effectiveness, *COMPARATIVE studies, *RANDOMIZED controlled trials, *RESEARCH funding, *METFORMIN, *MEDICAL prescriptions, *LONGITUDINAL method